# Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers

> **NCT00432770** · PHASE1 · COMPLETED · sponsor: **Archemix Corp.** · enrollment: 42 (—)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** ARC1779

## Key facts

- **NCT ID:** NCT00432770
- **Lead sponsor:** Archemix Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 42 (—)
- **Last updated:** 2007-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432770, "Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT00432770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*